Skip to content

Renal artery nerve interruption guided by location and electrical stimulation

Renal denerVatiOn under anatomicaL and elecTrical guidance

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON23038
Enrollment
20
Registered
2016-04-11
Start date
2016-06-01
Completion date
Unknown
Last updated
2025-03-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Essential hypertension

Interventions

- renal nerve stimulation - renal denervation - hyperemic pressure and flow measurements

Sponsors

VU medical center
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: - Essential hypertension - Three antihypertensive drugs, of which one a diuretic

Exclusion criteria

Exclusion criteria: - Age > 65 y - Ambulantory blood pressure > 180/110 mmHg in the absence of antihypertensive medication - Renal clearance < 60 ml/min (MDRD) - Secundairy hypertension

Design outcomes

Primary

MeasureTime frame
- to study blood pressure changes in response to electrical stimulation pre- and post-ablation

Secondary

MeasureTime frame
- to study the effect of renal denervation on renal blood flow as expressed by renal flow reserve and resistance index. - to study the effect of renal denervation on office- and ambulatory blood pressure. - to study the effect of renal denervation on the efferent sympathetic nervous system activity as expressed by catecholamine levels and natriuresis. - to study the effect of RDN on central sympathetic nervous activity as expressed by heart rate variability and peripheral arterial tonometry.

Contacts

Public ContactAlexander Nap

VUmc

a.nap@vumc.nltel: +31 20 4444444

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)